12:00 AM
Aug 28, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Beta LT: Began Phase I/II testing

LifeTime Pharmaceuticals Inc., Silver Spring, Md.
Product: Beta LT
Business: Cancer
Therapeutic category: Immune stimulation
Target: Lymphocytes
Description: Beta-alethine immune stimulant

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >